コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al hemorrhage and 77.4% [24 of 31] for acute subarachnoid hemorrhage).
2 SH score (Functional Recovery Expected after Subarachnoid Hemorrhage).
3 es/L after excluding patients diagnosed with subarachnoid hemorrhage).
4 ot in control patients with intracerebral or subarachnoid hemorrhage.
5 Federation of Neurosurgical Societies, 3-5) subarachnoid hemorrhage.
6 ical-device associated hemolysis, or after a subarachnoid hemorrhage.
7 an, and ischemic lesion within 72 hours from subarachnoid hemorrhage.
8 safe procedure for patients with poor-grade subarachnoid hemorrhage.
9 eadache requiring investigations to rule out subarachnoid hemorrhage.
10 27.5% (95% CI, 25.6%-29.5%) specificity for subarachnoid hemorrhage.
11 d with LRDA were intracranial hemorrhage and subarachnoid hemorrhage.
12 f the 2131 enrolled patients, 132 (6.2%) had subarachnoid hemorrhage.
13 AH Rule was highly sensitive for identifying subarachnoid hemorrhage.
14 n the CA group, 1 patient died at 1 month of subarachnoid hemorrhage.
15 s occur during the early phase of aneurysmal subarachnoid hemorrhage.
16 nt of hemorrhage in patients with aneurysmal subarachnoid hemorrhage.
17 efficacy of RIPC in protecting brain against subarachnoid hemorrhage.
18 d brain edema at 24 hrs but not 72 hrs after subarachnoid hemorrhage.
19 prevent cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
20 ales aged 5 to 14 years showed increases for subarachnoid hemorrhage.
21 ents had intracerebral hemorrhage, and 4 had subarachnoid hemorrhage.
22 entified as an important cause of stroke and subarachnoid hemorrhage.
23 nt is effective for early brain injury after subarachnoid hemorrhage.
24 scular contraction that follows experimental subarachnoid hemorrhage.
25 s 22 yrs, and a majority (63%) had traumatic subarachnoid hemorrhage.
26 rkedly suppressed basilar artery spasm after subarachnoid hemorrhage.
27 outcome among patients with acute aneurysmal subarachnoid hemorrhage.
28 -fold in patients after TBI and nontraumatic subarachnoid hemorrhage.
29 my among good-grade patients with aneurysmal subarachnoid hemorrhage.
30 tion]) were routinely referred for DSA after subarachnoid hemorrhage.
31 rction and for evaluation of vasospasm after subarachnoid hemorrhage.
32 eurysms, in patients with nontraumatic acute subarachnoid hemorrhage.
33 an adverse effect on cerebral ischemia after subarachnoid hemorrhage.
34 cephalus, one hemorrhagic contusion, and one subarachnoid hemorrhage.
35 per hour was started within 72 hours of the subarachnoid hemorrhage.
36 patients with acute brain injury, including subarachnoid hemorrhage.
37 tal detection of UIA and no prior history of subarachnoid hemorrhage.
38 lmark of delayed cerebral ischemia following subarachnoid hemorrhage.
39 from patients with traumatic brain injury or subarachnoid hemorrhage.
40 the patient died after an acute large-volume subarachnoid hemorrhage.
41 ts with perimesencephalic (PM) nonaneurysmal subarachnoid hemorrhage.
42 he argon group was discovered 24 hours after subarachnoid hemorrhage.
43 assessment of consciousness in patients with subarachnoid hemorrhage.
44 ncluding stroke, traumatic brain injury, and subarachnoid hemorrhage.
45 beneficial effect of argon application after subarachnoid hemorrhage.
46 The primary objective was mortality after subarachnoid hemorrhage.
47 rmed of 83 consecutively treated adults with subarachnoid hemorrhage.
48 ool for risk stratification after aneurysmal subarachnoid hemorrhage.
49 ial bleeding, specifically intracerebral and subarachnoid hemorrhages.
50 patients: adjusted odds ratios (95% CI) for subarachnoid hemorrhage 0.17 (0.06-0.45) and intracerebr
51 was lower in patients with thick versus thin subarachnoid hemorrhage (1.92 vs 1.99 mg/dL; p = 0.022).
52 with traumatic brain injury, 10% to 14% with subarachnoid hemorrhage, 1% to 21% with intracerebral he
53 n-Hispanic black patients aged 45 to 54 with subarachnoid hemorrhage (13.2/10000 to 10.3/10000 hospit
55 raphic hemorrhage; 1, thin [< 1 mm in depth] subarachnoid hemorrhage; 2, thin subarachnoid hemorrhage
58 ing and 2) an open-field test 24 hours after subarachnoid hemorrhage, 3) protein analysis of hippocam
59 c stroke (19%), 936 ventilated patients with subarachnoid hemorrhage (32%), and 1,404 ventilated pati
60 Of 383 patients enrolled, there were 128 subarachnoid hemorrhage (33.4%), 134 subdural hematoma (
63 raventricular hemorrhage; 3, thick [>= 1 mm] subarachnoid hemorrhage; 4, thick subarachnoid hemorrhag
64 and 131 met CT criteria for PM nonaneurysmal subarachnoid hemorrhage (53 women; mean age, 53 years [r
66 % vs. 32%), and more intracranial pathology (subarachnoid hemorrhage 62% vs. 44%; intraparenchymal le
67 ident strokes were documented, including 119 subarachnoid hemorrhages, 62 intraparenchymal hemorrhage
72 Fourteen patients were hospitalized after subarachnoid hemorrhage and 2 patients were hospitalized
73 to determine the proportion of patients with subarachnoid hemorrhage and acute lung injury who a rece
74 ology of types of stroke, such as aneurysmal subarachnoid hemorrhage and cerebral vein thrombosis, th
75 l vasospasm is a frequent complication after subarachnoid hemorrhage and contributes to overall morbi
78 protective against early brain injury after subarachnoid hemorrhage and determined whether this effe
79 seizure like activity found to have diffuse subarachnoid hemorrhage and extensive dural venous sinus
80 rebral vasospasm in patients with aneurysmal subarachnoid hemorrhage and for guiding transfusion ther
81 Conclusion In patients with PM nonaneurysmal subarachnoid hemorrhage and initial DSA negative for ane
83 Acute lung injury is common in patients with subarachnoid hemorrhage and is independently associated
84 O administered for 8h improved recovery from subarachnoid hemorrhage and reduced the inflammatory res
85 ocity were improved between acute aneurysmal subarachnoid hemorrhage and stable state (p </= .005); c
87 lar hemoglobin decreases hypoperfusion after subarachnoid hemorrhage and that sustained hemodilution
90 ange of disorders including ischemic stroke, subarachnoid hemorrhage, and brain trauma, and suggest a
91 ies in patients with traumatic brain injury, subarachnoid hemorrhage, and intracranial hemorrhage hav
92 coma with traumatic brain injury, aneurysmal subarachnoid hemorrhage, and intracranial hemorrhage.
93 ute ischemic stroke, traumatic brain injury, subarachnoid hemorrhage, and postcardiac arrest anoxic e
95 hemorrhagic stroke, two ischemic stroke, one subarachnoid hemorrhage, and three control participants.
96 stroke, intracerebral hemorrhage, aneurysmal subarachnoid hemorrhage, and traumatic brain injury have
99 ved a single treatment of hemodilution after subarachnoid hemorrhage; and, for eight animals, treatme
100 lactate and glucose levels after aneurysmal subarachnoid hemorrhage are associated with delayed cere
101 chemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage as defined by validated diagnosi
102 ng injury in a large cohort of patients with subarachnoid hemorrhage as well as determine the risk fa
103 VSP) is a common phenomenon after aneurysmal subarachnoid hemorrhage (aSAH) and contributes to neuroc
104 nosis of patients with high-grade aneurysmal subarachnoid hemorrhage (aSAH) is only insufficiently di
105 ed the prognosis differed between aneurysmal subarachnoid hemorrhage (aSAH) patients with surgical cl
107 adverse outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need f
108 layed cerebral ischemia following aneurysmal subarachnoid hemorrhage (aSAH), leading to high morbidit
109 asospasm is a dreaded sequelae of aneurysmal subarachnoid hemorrhage (aSAH), requiring timely interve
110 ociated with worse outcomes after aneurysmal subarachnoid hemorrhage (aSAH), there is no consensus on
111 es to a devastating outcome after aneurysmal subarachnoid hemorrhage (aSAH), with limited therapeutic
114 2000 to 2013, 252 consecutive patients with subarachnoid hemorrhage at computed tomography (CT) and
118 to prevent early rebleeding after aneurysmal subarachnoid hemorrhage, but anticoagulation and induced
119 feasible in patients with intracerebral and subarachnoid hemorrhage, but has yet to be tested in a p
120 e axonal injury, intraventricular hemorrhage/subarachnoid hemorrhage, complete cisternal effacement,
121 (brain infarction, intracerebral hemorrhage, subarachnoid hemorrhage, coronary heart disease and deat
122 ed protein levels in humans after aneurysmal subarachnoid hemorrhage correlate with the degree of cer
124 redict 60-day case fatality after aneurysmal subarachnoid hemorrhage developed from the International
125 rted on a case of a 16-year-old patient with subarachnoid hemorrhage diagnosed due to a ruptured cere
126 dministration of sodium nitrite after severe subarachnoid hemorrhage differentially influences quanti
128 ees of freedom = 1; p < 0.001), higher daily Subarachnoid hemorrhage Early Brain Edema Score (adjuste
129 logical scores (modified Fisher Scale (mFS), Subarachnoid Hemorrhage Early Brain Edema Score) (P < 0.
130 ter than 48 hours (hydrocephalus; high-grade Subarachnoid Hemorrhage Early Brain Edema Score), greate
131 dema Score), greater than 7 days (high-grade Subarachnoid Hemorrhage Early Brain Edema Score, co-occu
133 four percent of participants with aneurysmal subarachnoid hemorrhage experienced augmented renal clea
135 nterventions for intracerebral hemorrhage or subarachnoid hemorrhage generally hinge on whether they
139 morbidity and mortality following aneurysmal subarachnoid hemorrhage; however, the effect of acute lu
140 hemorrhage (HR 26.9; 95% CI 20.3-35.6), and subarachnoid hemorrhage (HR 21.6; 95% CI 12.2-38.1).
141 hemorrhage (HR, 0.85; 95% CI, 0.74-0.96) and subarachnoid hemorrhage (HR, 0.82; 95% CI, 0.69-0.96).
142 al hemorrhage (HR, 1.9; 95% CI, 1.5-2.4) and subarachnoid hemorrhage (HR, 2.4; 95% CI, 1.7-3.5) than
145 f nonaneurysmal perimesencephalic pattern of subarachnoid hemorrhage in ruptured vertebrobasilar aneu
146 common complication in the first week after subarachnoid hemorrhage in severe cases admitted to ICU.
147 chemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage in the Get With the Guidelines-S
148 e young age and high prevalence of traumatic subarachnoid hemorrhage in this cohort may limit its gen
151 luding migraine, ischemic stroke, aneurysmal subarachnoid hemorrhage, intracerebral hematoma, and tra
153 al centers were eligible if they a) suffered subarachnoid hemorrhage, intracerebral hemorrhage, ische
154 ointensive care," "neurological," "stroke," "subarachnoid hemorrhage," "intracerebral hemorrhage," or
155 eated with an equal volume (1 microL) of pre-subarachnoid hemorrhage intracerebroventricular administ
157 hereas gabapentin/pregabalin were favored in subarachnoid hemorrhage, intracranial hemorrhage, spine,
159 s primary cerebral vasculitis and aneurysmal subarachnoid hemorrhage is common because of overlapping
160 imal timing of tracheostomy in patients with subarachnoid hemorrhage is controversially debated.
162 that the primary cause of poor outcome after subarachnoid hemorrhage is not only cerebral arterial na
163 ular outcomes, including ischemic stroke and subarachnoid hemorrhage, leading to long-term physical a
167 ssociated with inferior outcomes, to compare subarachnoid hemorrhage mortality with other neurologica
168 , intracerebral hemorrhage (n = 97,709), and subarachnoid hemorrhage (n = 27,334) among Hispanics, Bl
171 r III ("good-grade patients"), who had had a subarachnoid hemorrhage no more than 14 days before plan
172 tion with isoflurane in patients with severe subarachnoid hemorrhage not having intracranial hyperten
173 95% CI, 0.14-0.77; p = 0.011) and with thick subarachnoid hemorrhage (odds ratio 0.29 per 1 mg/dL inc
174 confidence interval 0.82-0.90), diagnosis of subarachnoid hemorrhage (odds ratio 2.44, confidence int
175 of 287 adult patients with acute aneurysmal subarachnoid hemorrhage of all clinical grades were anal
177 defined as the presence of intracerebral or subarachnoid hemorrhage on computed tomography or magnet
179 ubstantial group of patients with aneurysmal subarachnoid hemorrhage or intracerebral hemorrhage expe
182 onsecutive volume-resuscitated patients with subarachnoid hemorrhage or traumatic brain injury, witho
185 res (OR, 3.20; 95% CI, 1.76-5.82; P < .001), subarachnoid hemorrhage (OR, 2.43; 95% CI, 1.22-4.83; P
186 (odds ratio [OR], 2.494), the indication of subarachnoid hemorrhage (OR, 2.523), and the comorbidity
187 rhages, whereas SCARA5 decreased the risk of subarachnoid hemorrhage (OR=0.61; 95% CI, 0.47-0.81; P=5
188 ients had traumatic brain injury, aneurysmal subarachnoid hemorrhage, or intracerebral hemorrhage; he
192 ly and particularly to vulnerable regions in subarachnoid hemorrhage patients at risk for delayed cer
193 omparison with other neurological diagnoses, subarachnoid hemorrhage patients had significantly great
194 udy was to describe in-hospital mortality in subarachnoid hemorrhage patients requiring ICU admission
195 lity physiological recordings in 48 comatose subarachnoid hemorrhage patients to better characterize
199 neurological outcome in good-grade surgical subarachnoid hemorrhage patients, as assessed by the Gla
203 time points: on admission (acute aneurysmal subarachnoid hemorrhage phase) and at least 21 days late
204 orrhage severity in patients with aneurysmal subarachnoid hemorrhage, potentially through a hemostati
205 determinant of outcome with intracranial or subarachnoid hemorrhage predicting a extremely high mort
206 ation rates for intracerebral hemorrhage and subarachnoid hemorrhage remained stable, with the except
207 hemorrhage (RR: 0.96; 95% CI: 0.84, 1.10) or subarachnoid hemorrhage (RR: 1.01; 95% CI: 0.90, 1.14).
208 onin I (cTI) release occurs frequently after subarachnoid hemorrhage (SAH) and has been associated wi
209 atable condition in patients with aneurysmal subarachnoid hemorrhage (SAH) and has been associated wi
210 netically altered mice include occurrence of subarachnoid hemorrhage (SAH) and variability of infarct
211 ebral vasospasm during the 14 days after the subarachnoid hemorrhage (SAH) are considered the leading
212 ce of intracranial aneurysms (IA) and suffer subarachnoid hemorrhage (SAH) at younger ages than the g
215 Cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) has devastating consequenc
216 in acute brain injury but an involvement in subarachnoid hemorrhage (SAH) has not been investigated.
217 mic neurological damage following aneurysmal subarachnoid hemorrhage (SAH) have remained elusive.
227 rospective observational study of aneurysmal subarachnoid hemorrhage (SAH) patients, we explored the
231 ness (LOC) is a common presenting symptom of subarachnoid hemorrhage (SAH) that is presumed to result
234 dysfunction has been reported in humans with subarachnoid hemorrhage (SAH), and its underlying pathop
235 stoperative ICU management of patients after subarachnoid hemorrhage (SAH), especially with regards t
236 studies have shown that for the treatment of subarachnoid hemorrhage (SAH), outcomes are improved but
237 m is usually associated with the presence of subarachnoid hemorrhage (SAH), SAH is not required for v
238 To begin to examine HO activity following subarachnoid hemorrhage (SAH), the expression of HO-1 an
253 tic meningitis only (six patients with acute subarachnoid hemorrhage [SAH] excluded), the sensitivity
254 e polycystic kidney disease, presenting with subarachnoid hemorrhage secondary to a ruptured intracra
255 y include drug overdose, pulmonary embolism, subarachnoid hemorrhage, seizure, anaphylaxis, and infec
259 ncreased due to sympathetic activation after subarachnoid hemorrhage similar to critically ill patien
260 diagnoses, and to explore the variability in subarachnoid hemorrhage standardized mortality ratios.
262 should be maintained even if the pattern of subarachnoid hemorrhage suggests a nonaneurysmal origin
263 w-onset stroke, intracerebral hemorrhage, or subarachnoid hemorrhage support these observations.
264 ts with TBI, five patients with nontraumatic subarachnoid hemorrhage, ten nonneurologic controls, and
268 d of operation in patients with nontraumatic subarachnoid hemorrhage they were 104 +/- 68 ng/mL (p =
269 ated with poor outcome, but after aneurysmal subarachnoid hemorrhage, this has not been investigated.
270 brain, including traumatic brain injury and subarachnoid hemorrhage, thus improvement in outcome may
272 Urgent surgery patients and patients with a subarachnoid hemorrhage, trauma, acute renal failure, or
273 atients with acute brain injury secondary to subarachnoid hemorrhage, traumatic brain injury, primary
276 isher scale) and dichotomized (thick vs thin subarachnoid hemorrhage) univariate and adjusted logisti
279 als were randomly assigned to sham-operated, subarachnoid hemorrhage-vehicle, and subarachnoid hemorr
280 At baseline, the severity of aneurysmal subarachnoid hemorrhage was assessed clinically (Hunt an
282 ng manual PVI (1%), an SCL with asymptomatic subarachnoid hemorrhage was detected; the bleeding compl
288 spital between 2006 and 2011 with poor-grade subarachnoid hemorrhage were prospectively entered into
289 y-five consecutive adult patients with acute subarachnoid hemorrhage were recruited into the institut
292 se in the prevalence of hospitalizations for subarachnoid hemorrhage, whereas females aged 5 to 14 ye
293 y identification of patients with aneurysmal subarachnoid hemorrhage who are at high risk for symptom
294 omatose patients with high-grade spontaneous subarachnoid hemorrhage who underwent continuous surface
295 e consecutive patients with acute (<14 days) subarachnoid hemorrhage who underwent GDC embolization w
297 al aneurysm (CA) rupture is a major cause of subarachnoid hemorrhage with high morbidity and mortalit
298 m in depth] subarachnoid hemorrhage; 2, thin subarachnoid hemorrhage with intraventricular hemorrhage
299 [>= 1 mm] subarachnoid hemorrhage; 4, thick subarachnoid hemorrhage with intraventricular hemorrhage
300 ctive properties of argon after experimental subarachnoid hemorrhage with mortality as the primary en